Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-27.32%
operating margin TTM
-27.68%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -49.94 |
| peg ratio | -0.96 |
| price to book ratio | 28.43 |
| price to sales ratio | 10.78 |
| enterprise value multiple | -43.21 |
| price fair value | 28.43 |
profitability ratios | |
|---|---|
| gross profit margin | 93.07% |
| operating profit margin | -27.68% |
| pretax profit margin | -27.32% |
| net profit margin | -27.32% |
| return on assets | -25.21% |
| return on equity | -50.15% |
| return on capital employed | -35.26% |
liquidity ratios | |
|---|---|
| current ratio | 3.50 |
| quick ratio | 3.16 |
| cash ratio | 0.67 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 521.21 |
| operating cycle | 581.59 |
| days of payables outstanding | 282.77 |
| cash conversion cycle | 298.82 |
| receivables turnover | 6.04 |
| payables turnover | 1.29 |
| inventory turnover | 0.70 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.01 |
| interest coverage | -28.01 |
| cash flow to debt ratio | -38.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -9.38 |
| cash per share | 28.00 |
| operating cash flow per share | -9.23 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -38.40 |
| short term coverage ratios | -157.98 |
| capital expenditure coverage ratio | -62.12 |
Frequently Asked Questions
When was the last time Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reported earnings?
Madrigal Pharmaceuticals, Inc. (MDGL) published its most recent earnings results on 06-05-2026.
What is Madrigal Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)'s trailing twelve months ROE is -50.15%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Madrigal Pharmaceuticals, Inc. (MDGL) currently has a ROA of -25.21%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MDGL's net profit margin stand at?
MDGL reported a profit margin of -27.32% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MDGL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.50 in the most recent quarter. The quick ratio stood at 3.16, with a Debt/Eq ratio of 0.01.